A nonantibiotic approach for treating urinary tract infections
New American Chemical Society podcast
2012-08-15
(Press-News.org) WASHINGTON, Aug. 15, 2012 — The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a potential new approach for treating urinary tract infections (UTIs) — which affect millions of people annually — without traditional antibiotics. Because it involves non-antibiotic compounds, the approach would not contribute to the growing problem of antibiotic-resistant bacteria, or "superbugs."
Based on a report by Beat Ernst, Ph.D., and colleagues in ACS' Journal of Medicinal Chemistry, the new podcast is available without charge at iTunes and from www.acs.org/globalchallenges.
In the podcast, Ernst explains that antibiotics are the mainstay treatment for UTIs. Bacteria, however, are developing resistance to common antibiotics, with the emergence of superbugs that shrug off some of the most powerful new antibiotics.
Thus, the scientists decided to try a new approach — developing substances that target bacteria virulence factors, inhibiting them from sticking to the inside of the urinary bladder. Hence, microbes are not able to launch an infection. In addition, this new class of antimicrobials is expected to have a reduced potential for the emergence of resistant microbes.
The scientists describe the development of anti-adhesion molecules that specifically interfere with the attachment of bacteria to human bladder cells. The most potent of the substances prevented a UTI from developing in mice (stand-ins for humans in this kind of experiment) for more than eight hours. In the in vivo treatment study, a very low dose reduced the amount of bacteria in the bladder of the animals by almost 10,000 times, which is comparable to the standard antibiotic treatment with ciprofloxacin.
INFORMATION:
Global Challenges/Chemistry Solutions is a series of podcasts describing some of the 21st century's most daunting problems, and how cutting-edge research in chemistry matters in the quest for solutions. Global Challenges is the centerpiece in an alliance on sustainability between ACS and the Royal Society of Chemistry. Global Challenges is a sweeping panorama of global challenges that includes dilemmas such as providing a hungry and thirsty world with ample supplies of safe food and clean water, developing alternatives to petroleum to fuel society, preserving the environment and ensuring a sustainable future for our children and improving human health.
For more entertaining, informative science videos and podcasts from the ACS Office of Public Affairs, view Prized Science, Spellbound, Science Elements and Global Challenges/Chemistry Solutions.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 164,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-08-15
WASHINGTON, Aug. 15, 2012 — Progress toward developing an alternative to organ transplantations in which doctors could actually grow a new heart or liver for a patient is among the topics in the 2012 premier of a popular video series from the American Chemical Society (ACS), the world's largest scientific society. The videos are available at www.acs.org/PrizedScience and on DVD.
Titled Prized Science: How the Science Behind American Chemical Society Awards Impacts Your Life, the first episode of the 2012 series features the research of Dr. Robert Langer, winner of the ...
2012-08-15
VIDEO:
This computer animation, created using new software called Arepo, simulates nine billion years of cosmic history. Arepo can accurately follow the birth and evolution of thousands of galaxies over billions...
Click here for more information.
Scientists at the Harvard-Smithsonian Center for Astrophysics (CfA) and their colleagues at the Heidelberg Institute for Theoretical Studies (HITS) have invented a new computational approach that can accurately follow the birth and ...
2012-08-15
EAST LANSING, Mich. — A professor at Michigan State University is part of a team developing a new method of removing phosphorous from our wastewater – a problem seriously affecting lakes and streams across the country.
In addition, Steven Safferman, an associate professor of biosystems and agricultural engineering, and colleagues at Columbus, Ohio, based-MetaMateria Technologies, are devising a cost-effective way of recovering the phosphorous, which then can be reused for fertilizer products.
Although its use is regulated in many states, including Michigan, in items ...
2012-08-15
In public comments submitted yesterday, People for the Ethical Treatment of Animals (PETA) applauds the United States Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) for announcing its plans to allow firms to secure exemptions from the target animal batch safety tests (TABST) that have until now been required for each batch of veterinary biologics products, including live and inactivated vaccines. In draft memorandum 453, USDA states that CVB intends to consider TABST exemptions in line with recommendations in the TABST waiver guideline drafted by ...
2012-08-15
Amid policy debate over potential liquefied natural gas (LNG) exports from the United States, a new paper from Rice University's Baker Institute for Public Policy predicts the long-term volume of exports from the U.S. will not likely be very large. The paper also argues that the impact on U.S. domestic natural gas prices will not be large if exports are allowed by the U.S government.
Significant changes in the global gas market in the past decade, particularly the emergence of shale in North America, have dramatically altered the global outlook for LNG markets and ...
2012-08-15
Amsterdam, NL, August 15, 2012 – In a study published in the current issue of Restorative Neurology and Neuroscience scientists report that a therapy combining exercise with the neurovascular protective agent S-nitrosoglutathione (GSNO) improved recovery from stroke in a rat model. GSNO is a compound found naturally in the body and it has no known side effects or toxicity.
"In our study, GSNO or motor exercise provided neuroprotection, reduced neuronal cell death, maintained tissue structure, and aided functional recovery by stimulating the expression of neuronal repair ...
2012-08-15
The World Health Organization estimates that in 2011 there were 216 million cases of malaria and 34.2 million people living with HIV. These diseases particularly afflict sub-Saharan Africa, where large incidence of co-infection result in high mortality rates. Yet, in spite of this global pandemic, interactions between the parasite that causes malaria, Plasmodium falciparum, and HIV-1 are poorly understood. However, a new video article in JoVE, the Journal of Visualized Experiments, that describes a novel technique to study the interactions between HIV-1 and P. falciparum ...
2012-08-15
BOSTON--The genomic tumult within tumor cells has provided scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard with clues to an entirely new class of genes that may serve as an Achilles' heel for many forms of cancer.
As reported in the Aug. 17 issue of the journal Cell, the researchers identified 56 such genes, only a few of which had previously been identified as potential targets for cancer therapy. Unlike most such targets, these genes don't cause normal cells to turn cancerous. Instead, they are essential to all cells but have been ...
2012-08-15
PHILADELPHIA — Treatment with denosumab resulted in a greater reduction in skeletal-related events in patients with breast cancer that spread to the bones compared with zoledronic acid, while also maintaining health-related quality of life, according to the results of a phase III study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
"Our data indicate that denosumab should be the treatment of choice for the prevention of skeletal-related events and hypercalcemia in patients with breast cancer that has metastasized to the ...
2012-08-15
How the intricate network of blood vessels forms within the brain has long fascinated biologists. Though the human brain comprises only 2 percent of body weight it receives up to 15 percent of the cardiac output through this network, or vessel vasculature. The vasculature in the human brain consists of a complex branching network of blood vessels, in total some several hundred miles in length. The network is formed so as to distribute blood efficiently to all brain regions, and abnormalities can lead to various neurological disorders, including strokes, learning difficulties ...
LAST 30 PRESS RELEASES:
[Press-News.org] A nonantibiotic approach for treating urinary tract infections
New American Chemical Society podcast
